Outcome of treatment in adult acute lymphoblastic leukemia in Southern Brazil using a modified German multicenter acute lymphoblastic leukemia protocol

Acta Haematologica

Volumn 107, Issue 4, 2002, Pages 203-207

  Fogliatto, L ^a   Bittencourt, H ^a   Nunes, A S ^a   Salenave, P R ^a   Silva, G S ^a   Daudt, L E ^a   Job, F M ^a   Bittencourt, R ^a   Onsten, T ^a   Silla, L M R ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Acute leukemia; Adult; Brazil; Chemotherapy; Outcome

Indexed keywords

ANTILEUKEMIC AGENT; ASPARAGINASE; CD19 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; TENIPOSIDE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ANTIGEN EXPRESSION; ARTICLE; BRAZIL; CENTRAL NERVOUS SYSTEM DISEASE; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTODIAGNOSIS; FEMALE; HUMAN; IMMUNOPHENOTYPING; MALE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; PROPHYLAXIS; PUBLIC HEALTH SERVICE; REMISSION; RISK FACTOR; SURVIVAL RATE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIGENS, CD19; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAZIL; DEVELOPING COUNTRIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, LYMPHOCYTIC, ACUTE, L2; LIFE TABLES; MALE; MIDDLE AGED; NEPRILYSIN; PHILADELPHIA CHROMOSOME; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 18444411316     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000058315     Document Type: Article

References (31)

1. Curing children of leukemia
2. Controversies in the management of childhood acute lymphoblastic leukemia: Treatment intensification, CNS leukemia and prognostic factors
3. Comparative analysis of treatment programs for childhood acute lymphoblastic leukemia
4. Acute lymphoblastic leukemia: Recent advances in biology and therapy
5. Acute lymphoblastic leukemia in adults: Recent progress, future directions
6. The road to the cure of acute lymphoblastic leukemia: A personal perspective
7. The challenge of acute lymphoblastic leukaemia in adults
8. Therapy of the newly diagnosed adult with acute lymphoblastic leukemia
9. Treatment of acute lymphoblastic leukemia
10. Acute leukemia
11. The impact of age on outcome in lymphoblastic leukaemia; MRC UKALL X and XA compared: A report from the MRC paediatric and adult working parties
12. Adolescent and adult acute lymphoblastic leukemia: Prognostic features and outcome of therapy. A study of 293 patients
13. GIMEMA ALL 0183: A multi-centric study on adult acute lymphoblastic leukaemia in Italy
14. Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults
15. Immunophenotypic and genotypic features, clinical characteristics, and treatment outcome of adult pro-B acute lymphoblastic leukemia: Results of the German multicenter trials GMALL 03/87 and 04/89
16. A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia
17. Treatment of adult acute lymphoblastic leukemia
18. Cytarabine with high-dose mitoxantrone induces rapid complete remissions in adult lymphoblastic leukemia without the use of vincristine and prednisone
19. Estimated 6-year event-free survival of 55% in 60 consecutive adult acute lymphoblastic leukemia patients treated with an intensive phase II protocol based on a high induction dose of daunorubicin
20. High-dose chemotherapy in adult acute lymphoblastic leukemia
21. Teniposide (VM-26) and cytosine arabinoside as consolidation therapy in adult high-risk patients with acute lymphoblastic leukemia
22. Hypersensivity reactions to L-asparaginase do not impact on the remission duration of adults with acute lymphoblastic leukemia
23. Outcome of treatment in adult acute lymphoblastic leukaemia in an Asian population: Comparison with a previous multicentre German study
24. High efficacy of the German multicenter ALL (GMALL) protocol for treatment of adult acute lymphoblastic leukemia (ALL) - A single-institution study
25. Improved treatment outcome in adult acute lymphoblastic leukemia using the intensive German protocol, a preliminary report
26. Therapy of acute lymphoblastic leukemia in adults
27. Immunophenotype of adult acute lymphoblastic leukemia, clinical parameters and outcomes: An analysis of a prospective trial, including 562 tested patients (LALA87)
28. Treatment of adult acute lymphoblastic leukemia with intensive cyclical chemotherapy: A follow-up report
29. The biology and treatment of acute lymphoblastic leukemia in adults
30. Intensive therapy for adult acute leukemia
31. Results of the vincristine, doxorubicin, and dexametasone regimen in adutls with standard- and high-risk acute lymphocytic leukemia